Skip to main content
Figure 5 | Diagnostic Pathology

Figure 5

From: MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4

Figure 5

Changes in anti-tumour effects of the cisplatin after transfection of anti-miR-182 and/or siRNA against PDCD4 in A549 cells. The MTT assay indicated a weaker anti-tumour effect of cisplatin following transfection of PDCD4 siRNA, and the enhanced growth-inhibitory effect by anti-miR-182 transfection was also weakened after the addition of PDCD4 siRNA (*P <0.05).

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us